|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|BIOVF||Swedish Orphan Biovitrum||19.50||0.00||0%||5.8B|
You can purchase shares of Swedish Orphan Biovitrum (OTC: BIOVF) through any online brokerage.
There are no as such competitors for Swedish Orphan Biovitrum.
The latest price target for Swedish Orphan Biovitrum (OTC: BIOVF) was reported by Barclays on February 24, 2021. The analyst firm set a price target for 0.00 expecting BIOVF to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Swedish Orphan Biovitrum (OTC: BIOVF) is $19.5 last updated Mon Jun 14 2021 19:35:10 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Swedish Orphan Biovitrum.
Swedish Orphan Biovitrum does not have any upcoming earnings scheduled.
There is no upcoming split for Swedish Orphan Biovitrum.
Swedish Orphan Biovitrum is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.